<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02624050</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003830</org_study_id>
    <nct_id>NCT02624050</nct_id>
  </id_info>
  <brief_title>Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs</brief_title>
  <official_title>Comparison of Methohexital With Propofol for Anesthetic Induction in Patients Treated With an Antagonist of the Renin-Angiotensin System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient undergoing general anesthesia in elective surgery will be assigned to receive either
      methohexital or propofol general anesthesia. Hypotensive events during the first 15 minutes
      of induction will be compared between the groups to ascertain which drug is less likely to
      cause a hypotensive event.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients taking angiotensin converting-enzyme inhibitors (ACEIs) or angiotensin receptor
      blockers (ARBs) are susceptible to hypotensive events during general anesthesia. The purpose
      of this study is to determine if the use of either methohexital or propofol general
      anesthesias is more likely to result in hypotensive events in these patients during their
      induction. Hemodynamic metrics like blood pressure, mean arterial pressure, and heart rate
      will be monitored during the induction process, under both drugs, for use as the main
      metrics, as well as the need for vasopressors in response to patient hypotension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypotension in patient</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
    <description>Hypotensive events under either methohexital or propofol general anesthesia will be counted as the primary outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Refractory hypotension</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
    <description>Refractory hypotension is defined as a hypotensive event that continues after 3 doses of vasopressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of each hypotension episode</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood levels of AVP, AII, Epi, NE (at 3,5,10 and 15 min)</measure>
    <time_frame>Blood samples will be processed after collection and securely stored for analysis at a later time.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hypotension</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Methohexital</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methohexital will be administered intravenously as a general anesthetic at a dosage of 1.5mg per kg of patient body weight.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol will be administered intravenously as a general anesthetic at a dosage of 2.5mg per kg of patient body weight.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methohexital</intervention_name>
    <description>Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event.</description>
    <arm_group_label>Methohexital</arm_group_label>
    <other_name>Brevital</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event.</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  treated for at least 6 weeks with ACEIs or ARB

          -  undergoing elective surgery under general endotracheal anesthesia

          -  ASA Physical Class I or II

        Exclusion Criteria:

          -  BMI &gt;45kg/m^2

          -  taking both ACEI and ARB

          -  history of difficult intubation in the past

          -  require rapid sequence induction and intubation

          -  uncontrolled baseline blood pressure (SBP&gt;180mmHg or DBP &gt;110 mmHg) at anesthesia
             preoperative clinic visit

          -  contraindication to the use of propofol or methohexital

          -  significant coronary artery disease

          -  history of systolic heart failure

          -  history of renal failure (creatine level &gt;2 mg/dL)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Bonavia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anthony Bonavia, MD</last_name>
    <phone>717-531-6140</phone>
    <email>abonavia@hmc.psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ethan Reeder, BS</last_name>
    <phone>717-531-0003</phone>
    <phone_ext>289655</phone_ext>
    <email>ereeder2@hmc.psu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Penn State Milton S Hershey Medical Ctr</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ethan Reeder</last_name>
      <phone>717-531-8521</phone>
      <phone_ext>289655</phone_ext>
      <email>ereeder2@hmc.psu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001 Jan;92(1):26-30.</citation>
    <PMID>11133595</PMID>
  </reference>
  <reference>
    <citation>Carter JA, Clarke TN, Prys-Roberts C, Spelina KR. Restoration of baroreflex control of heart rate during recovery from anaesthesia. Br J Anaesth. 1986 Apr;58(4):415-21.</citation>
    <PMID>3954922</PMID>
  </reference>
  <reference>
    <citation>Cullen PM, Turtle M, Prys-Roberts C, Way WL, Dye J. Effect of propofol anesthesia on baroreflex activity in humans. Anesth Analg. 1987 Nov;66(11):1115-20.</citation>
    <PMID>3499095</PMID>
  </reference>
  <reference>
    <citation>Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992 May;76(5):725-33.</citation>
    <PMID>1575340</PMID>
  </reference>
  <reference>
    <citation>Eyraud D, Brabant S, Nathalie D, Fl√©ron MH, Gilles G, Bertrand M, Coriat P. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg. 1999 May;88(5):980-4.</citation>
    <PMID>10320155</PMID>
  </reference>
  <reference>
    <citation>Giudicelli JF, Berdeaux A, Edouard A, Richer C, Jacolot D. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol. 1985 Sep;20(3):211-8.</citation>
    <PMID>2994702</PMID>
  </reference>
  <reference>
    <citation>Gold MI, Abraham EC, Herrington C. A controlled investigation of propofol, thiopentone and methohexitone. Can J Anaesth. 1987 Sep;34(5):478-83.</citation>
    <PMID>3499244</PMID>
  </reference>
  <reference>
    <citation>Komatsu R, You J, Mascha EJ, Sessler DI, Kasuya Y, Turan A. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg. 2013 Dec;117(6):1329-37. doi: 10.1213/ANE.0b013e318299a516.</citation>
    <PMID>24257383</PMID>
  </reference>
  <reference>
    <citation>Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963-74.</citation>
    <PMID>7168798</PMID>
  </reference>
  <reference>
    <citation>Mets B. Management of hypotension associated with angiotensin-axis blockade and general anesthesia administration. J Cardiothorac Vasc Anesth. 2013 Feb;27(1):156-67. doi: 10.1053/j.jvca.2012.06.014. Epub 2012 Jul 31. Review.</citation>
    <PMID>22854335</PMID>
  </reference>
  <reference>
    <citation>Nielson E, Hennrikus E, Lehman E, Mets B. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery. J Hosp Med. 2014 May;9(5):283-8. doi: 10.1002/jhm.2155. Epub 2014 Jan 24.</citation>
    <PMID>24464761</PMID>
  </reference>
  <reference>
    <citation>Price ML, Millar B, Grounds M, Cashman J. Changes in cardiac index and estimated systemic vascular resistance during induction of anaesthesia with thiopentone, methohexitone, propofol and etomidate. Br J Anaesth. 1992 Aug;69(2):172-6.</citation>
    <PMID>1389822</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2015</study_first_submitted>
  <study_first_submitted_qc>December 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2015</study_first_posted>
  <last_update_submitted>August 1, 2017</last_update_submitted>
  <last_update_submitted_qc>August 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Anthony Bonavia</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>ACEI</keyword>
  <keyword>ARB</keyword>
  <keyword>Hypotension</keyword>
  <keyword>General Anesthesia</keyword>
  <keyword>Methohexital</keyword>
  <keyword>Propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Methohexital</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, General</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

